<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">79747</article-id><article-id pub-id-type="doi">10.7554/eLife.79747</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-277681"><name><surname>Ilter</surname><given-names>Metehan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300132"><name><surname>Kaşmer</surname><given-names>Ramazan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277683"><name><surname>Jalalypour</surname><given-names>Farzaneh</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275074"><name><surname>Atilgan</surname><given-names>Canan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0557-6044</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277684"><name><surname>Topcu</surname><given-names>Ozan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-300133"><name><surname>Karakaş</surname><given-names>Nihal</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-277686"><name><surname>Sensoy</surname><given-names>Ozge</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5950-3436</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">1Graduate School of Engineering and Natural Sciences</institution>, <institution>Istanbul Medipol University</institution>, <addr-line><named-content content-type="city">Istanbul</named-content></addr-line>, <country>Turkey</country></aff><aff id="aff2"><institution content-type="dept">Institute for Health Sciences and Technologies</institution>, <institution>Istanbul Medipol University</institution>, <addr-line><named-content content-type="city">Istanbul</named-content></addr-line>, <country>Turkey</country></aff><aff id="aff3"><institution content-type="dept">Faculty of Engineering and Natural Sciences</institution>, <institution>Sabanci University</institution>, <addr-line><named-content content-type="city">Istanbul</named-content></addr-line>, <country>Turkey</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-151091"><name><surname>Cui</surname><given-names>Qiang</given-names></name><role>Reviewing editor</role><aff><institution>Boston University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>nkarakas@medipol.edu.tr</email> (NK);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>osensoy@medipol.edu.tr</email> (OS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>12</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e79747</elocation-id><history><date date-type="received"><day>25</day><month>04</month><year>2022</year></date><date date-type="accepted"><day>30</day><month>11</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Ilter et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Ilter et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-79747-v1.pdf"/><abstract><p>Undruggability of RAS proteins has necessitated alternative strategies for the development of effective inhibitors. In this respect, phosphorylation has recently come into prominence as this reversible post-translational modification attenuates sensitivity of RAS towards RAF. As such, in this study, we set out to unveil the impact of phosphorylation on dynamics of HRAS<sup>WT</sup> and aim to invoke similar behavior in HRAS<sup>G12D</sup> mutant by means of small therapeutic molecules. To this end, we performed molecular dynamics (MD) simulations using phosphorylated HRAS and showed that phosphorylation of Y32 distorted Switch I, hence the RAS/RAF interface. Consequently, we targeted Switch I in HRAS<sup>G12D</sup> by means of approved therapeutic molecules and showed that the ligands enabled detachment of Switch I from the nucleotide-binding pocket. Moreover, we demonstrated that displacement of Switch I from the nucleotide-binding pocket was energetically more favorable in the presence of the ligand. Importantly, we verified computational findings in vitro where HRAS<sup>G12D</sup>/RAF interaction was prevented by the ligand in HEK293T cells that expressed HRAS<sup>G12D</sup> mutant protein. Therefore, these findings suggest that targeting Switch I, hence making Y32 accessible might open up new avenues in future drug discovery strategies that target mutant RAS proteins.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Health Institute of Turkey</institution></institution-wrap></funding-source><award-id>3561/2019-TA-02</award-id><principal-award-recipient><name><surname>Ilter</surname><given-names>Metehan</given-names></name><name><surname>Topcu</surname><given-names>Ozan</given-names></name><name><surname>Sensoy</surname><given-names>Ozge</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>The Scientific and Technological Research Council of Turkey</institution></institution-wrap></funding-source><award-id>116F229</award-id><principal-award-recipient><name><surname>Jalalypour</surname><given-names>Farzaneh</given-names></name><name><surname>Atilgan</surname><given-names>Canan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Simulated data used to generate the figures in the commentary are available online (https://osf.io/z2y5s/?view_only=070ebb995ba945bb9aac40d5979bd508).</p></sec><supplementary-material><ext-link xlink:href="elife-79747-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>